A 30-year-old woman presented with two years of progressive left face numbness which spread to left trunk, followed by progressive bilateral upper extremity numbness and weakness, and bilateral leg weakness. Her initial exam was notable for hypoesthesia in left V1/V2 distribution, spasticity in all extremities, distal more than proximal weakness in arms and legs, diffuse hyperreflexia and atrophy in bilateral hands.
Initial EMG showed active denervation with reinnervation in C7-T1 muscles. Vitamin B12, vitamin E, copper, TSH, ANA, ENA were normal. Serology was negative for VZV, celiac, HTLV I/II and Lyme. Ganglioside antibodies, Mayo clinic neuronal and paraneoplastic antibody panels, MRI C-spine and CSF studies were unremarkable. MRI brain demonstrated bilateral corticospinal tract degeneration.
She was empirically treated with steroids with subjective improvement in speech, dexterity and balance. However, her extremity weakness progressed and she developed dysarthria and dysphagia. Genetic analysis showed expansion of >30 hexanucleotide repeats in one copy of the C9orf72 gene, subsequently found in her biological father. No pathogenic mutation was noted in SOD1, TARBDP, CHCHD10, VCP, SQSTM1, PABPN1 genes.